Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of cabergoline in patients with rheumatoid arthritis
IRCT138802061828N2Phase 2Completed
- Sponsor
- Mazandaran University of Medical Sciences
- Start
- May 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of cabergoline in rheumatoid arthritis (RA), sponsored by Mazandaran University of Medical Sciences. Started May 2009; status: completed.
02
Drugs
cabergoline
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on IRCT138802061828N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT138802061828N2.